Emla (EMLA) Krem 25+25 mg/g איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

emla (emla) krem 25+25 mg/g

aspen pharma trading limited - lidocainum inn; prilocainum inn - krem - 25+25 mg/g

Engerix B Stungulyf, dreifa איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

engerix b stungulyf, dreifa

glaxosmithkline pharma a/s - lifrarbólgu b yfirborðsmótefnavaki - stungulyf, dreifa

Dexavit Stungulyf/innrennslislyf, lausn 4 mg/ml איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

dexavit stungulyf/innrennslislyf, lausn 4 mg/ml

vital pharma nordic aps - dexamethasonum natríumfosfat - stungulyf/innrennslislyf, lausn - 4 mg/ml

Puri-nethol Tafla 50 mg איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

puri-nethol tafla 50 mg

aspen pharma trading limited - mercaptopurinum inn - tafla - 50 mg

Cimzia האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

cimzia

ucb pharma sa - certolizumab pegol - crohn disease - Ónæmisbælandi lyf - cimzia, in combination with methotrexate (mtx), is indicated for the treatment of moderate to severe, active rheumatoid arthritis (ra) in adult patients when the response to disease-modifying antirheumatic drugs (dmard) including methotrexate, has been inadequate. Þegar hægt er að gefa eitt og sér í málið óþol stendur eða þegar áframhaldandi meðferð með stendur er óviðeigandi. cimzia has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function, when given in combination with methotrexate.